Could a tailored screening schedule beat the standard for breast cancer detection?

NCT ID NCT03672331

First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 23 times

Summary

This large international study is testing whether a personalized breast cancer screening plan—based on each woman's individual risk factors—works better than the standard one-size-fits-all approach. Over 53,000 women aged 40-70 are being followed for 4 years of different screening schedules, then monitored for 15 more years. The goal is to see if personalized screening can reduce the number of advanced (stage 2 or higher) breast cancers detected.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AUSL Reggio Emilia

    Reggio Emilia, Emilia-Romagna, Italy

  • Assuta Medical Center Ramat HaHayal

    Tel Aviv, Israel

  • Cambridge University Hospitals NHS Foundation Trust

    Cambridge, Cambridgeshire, United Kingdom

  • Gustave roussy

    Villejuif, France

  • Institut Jules Bordet

    Brussels, Belgium

  • Marta Romản

    Barcelona, Spain

Conditions

Explore the condition pages connected to this study.